0001209191-22-053457.txt : 20221012
0001209191-22-053457.hdr.sgml : 20221012
20221012161030
ACCESSION NUMBER: 0001209191-22-053457
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221010
FILED AS OF DATE: 20221012
DATE AS OF CHANGE: 20221012
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Thompson Rahsaan
CENTRAL INDEX KEY: 0001788524
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40502
FILM NUMBER: 221306958
MAIL ADDRESS:
STREET 1: 233 WILSHIRE BOULEVARD
STREET 2: SUITE 280
CITY: SANTA MONICA
STATE: CA
ZIP: 90401
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lyell Immunopharma, Inc.
CENTRAL INDEX KEY: 0001806952
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 833006753
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 HASKINS WAY
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650 695-0677
MAIL ADDRESS:
STREET 1: 201 HASKINS WAY
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-10-10
0
0001806952
Lyell Immunopharma, Inc.
LYEL
0001788524
Thompson Rahsaan
C/O LYELL IMMUNOPHARMA, INC.
201 HASKINS WAY
SOUTH SAN FRANICSCO
CA
94080
0
1
0
0
Chief Legal Officer
Option (right to buy)
6.91
2022-10-10
4
A
0
715000
0.00
A
2032-10-09
Common Stock
715000
715000
D
1/4 of the option shares shall vest on September 28, 2023, with the remaining option shares to vest in equal monthly installments over the following thirty-six months.
/s/ Hector Casab, as Attorney-in-Fact
2022-10-12